DUBLIN, April 28, 2021 /PRNewswire/ -- Medtronic plc (NYSE:MDT), the global leader in medical technology, today announced results from an interim analysis of the first 171 patients (including 71 ...
Please provide your email address to receive an email when new articles are posted on . An IV bolus of adenosine administered 10 minutes after radiofrequency ablation of the accessory pathway has the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback